Results 201 to 210 of about 107,786 (286)

Anti‐tumor necrosis factor‐α monotherapy versus combo therapy with immunosuppressant in pediatric inflammatory bowel disease: A real‐life study

Journal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objectives The aim of the study is to evaluate the efficacy of anti‐tumor necrosis factor (TNF)‐α monotherapy versus combination anti‐TNF‐α and immunosuppressive therapy. Methods A single‐center, retrospective, observational study was conducted on inflammatory bowel disease (IBD) children.
Flora Fedele, Massimo Martinelli, Caterina Strisciuglio, Elena Scarpato, Annamaria Staiano, Erasmo Miele   +5 more
wiley   +1 more source

Exploring Fall-Related Fracture Risk by Possible Fall-Risk Increasing Drugs in Japanese Older Adults Using Municipal Linked Medical and Long-Term Care Claim Data: A Nested Case-Control and Case-Crossover Study. [PDF]

Geriatr Gerontol Int
Nakano H, Iwagami M, Komiyama J, Sun Y, Hamasaki Y, Taniguchi Y, Kuroda N, Suzuki A, Tamiya N.   +8 more
europepmc   +1 more source

Adequate vitamin D is associated with favorable disease outcome in children with inflammatory bowel disease receiving anti‐tumor necrosis factor alpha therapy

Journal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objectives Deficiency of serum 25‐hydroxyvitamin D [25(OH)D] was associated with decreased short‐term response to anti‐tumor necrosis factor‐alpha (TNF‐α) agents in adults with inflammatory bowel disease (IBD). The aim of this study was to evaluate the association between serum 25(OH)D levels and the outcome of children with IBD undergoing ...
Adi Anafy, Yaara Manor, Maayan Shemer, Reut Doyev, Eytan Damari, Shlomi Cohen, Anat Yerushalmy‐Feler   +6 more
wiley   +1 more source

Anti-inflammatory pharmacotherapy in patients with cardiovascular disease. [PDF]

Eur Heart J Cardiovasc Pharmacother
Finocchiaro S, Mazzone PM, Ammirabile N, Bordonaro C, Cusmano C, Cutore L, Di Leo G, Faro DC, Giacoppo D, Greco A, Imbesi A, Mauro MS, Raffo C, Spagnolo M, Capodanno D.   +14 more
europepmc   +1 more source

Ruxolitinib and vedolizumab salvage therapy in the setting of cytomegalovirus colitis for a patient with newly diagnosed very early onset inflammatory bowel disease

JPGN Reports, EarlyView.
Abstract Acute severe ulcerative colitis increases the risk for cytomegalovirus (CMV) infection, particularly with the use of immunocompromising medications. We report a case of a 4‐year‐old with newly diagnosed very early onset inflammatory bowel disease presenting with acute severe colitis refractory to both corticosteroids and infliximab, whose ...
Alison Laxer, Morris Edelman, Julie Gallagher, Benjamin Sahn   +3 more
wiley   +1 more source

Cardiovascular and Thromboembolic Safety Signals Associated with Non-Steroidal Anti-Inflammatory Drugs Initiation: A Sequence Symmetry Analysis

Bobba SS, Rowlands E, Delmestri A, Man WY, Chen X, Li X, Saura-Lazaro A, Alhambra DP, Newby D.   +8 more
europepmc   +1 more source

Patterns of drug prescription among hospitalized patients in a tertiary women's hospital: A retrospective drug utilization study. [PDF]

J Int Med Res
Omidifar N, Mahi-Birjand M, Askari P, Abolzadeh Oskuie P, Karimzadeh I, Mirjalili M, Hoorang M, Peymani P.   +7 more
europepmc   +1 more source

Effect of beneficial microbes applications on nutritional profiles of organic tomatoes revealed by LC‐MS‐qTOF metabolomics

Journal of the Science of Food and Agriculture, EarlyView.
Abstract BACKGROUND The use of microorganisms and biostimulants is increasingly supported in agriculture because of their advantageous impact on plant disease management, growth enhancement and the synthesis of beneficial bioactive secondary metabolites (SMs). Tomato (Solanum lycopersicum) is an important crop and is consumed worldwide because it is an
Daria Lotito, Alessia Staropoli, Maria Isabella Prigigallo, Giuseppina Iacomino, Claudio Gigliotti, Giovanni Bubici, Sergio Bolletti‐Censi, Matteo Lorito, Francesco Vinale   +8 more
wiley   +1 more source

Targeting inflammation-metabolism crosstalk: current status and challenges of novel therapeutic strategies for osteoarthritis. [PDF]

Front Med (Lausanne)
Liu B, Zhang M, Gao L, Yang H.
europepmc   +1 more source

A Case of Pembrolizumab‐Induced Pityriasis Lichenoides‐Like Eruption Treated Successfully With Dupilumab

JEADV Clinical Practice, EarlyView.
ABSTRACT Immune‐checkpoint inhibitors (ICIs) have revolutionised melanoma treatment but can often cause severe and long‐standing cutaneous immune‐related adverse events (cirAEs). We report a case of refractory pembrolizumab‐induced pityriasis lichenoides (PL)‐like eruption successfully treated with dupilumab, leading to rapid and sustained remission ...
Evangelos Christou, Sharon Edwards, Andrew Affleck   +2 more
wiley   +1 more source